Switch to: References

Add citations

You must login to add citations.
  1. Mechanisms for Sustainable Post-Trial Access: A Perspective.P. Naidoo & V. Rambiritch - 2021 - South African Journal of Bioethics and Law 14 (3):77-78.
    Clinical trials are essential to establish the safety and efficacy of investigational products, contributing to risk/benefit assessments that ultimately determine whether these products meet the criteria for market authorisation. Clinical trials are also an important source of revenue and expertise generation for countries in which they are conducted. In developing countries, they represent substantial foreign direct investment. In spite of the substantial capital input that clinical trials require, the issue of funding post-trial access to beneficial therapies remains contentious, especially in (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Broadening the Debate About Post-Trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.J. Lawton, M. Blackburn, D. Rankin, C. Werner, C. Farrington, R. Hovorka & N. Hallowell - 2019 - AJOB Empirical Bioethics 10 (2):100-112.
    Download  
     
    Export citation  
     
    Bookmark   2 citations